- CureToday.com
- OncLive.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
Naval Daver, MD | Authors
Articles
Naval G. Daver, MD, on the Past Year in Acute Myeloid Leukemia Research
December 25, 2020
The leukemia expert offered an overview of agents approved by the FDA this year.
Naval Daver, MD, Provides Perspective on Updates in Acute Myeloid Leukemia
January 12, 2020
Naval Daver, MD, explains the progress made on 3 abstracts he’s involved with regarding acute myeloid leukemia (AML) at the ASH Annual Meeting and Exposition.
The Emerging Profile of Immunotherapy Approaches in the Treatment of AML
January 17, 2019
Dr. Daver discusses immunotherapy approaches for patients with acute myeloid leukemia (AML), and his recent study results on the combination of azacitidine and nivolumab.
Immunotherapy Approaches in AML
January 17, 2019
Cancer Network sat down with Dr. Naval Daver to discuss advancements and discoveries in immunotherapy for AML patients.